In female participants, ALT showed the most significant association with NAFLD (OR=1.60, 95% CI: 1.35-1.89), followed by GGT (OR=1.33, 95% CI: 1.15-1.52) and AST (OR=1.09, 95% CI: 1.00-1.18). This evidence concerns the gene GPT and metabolic dysfunction-associated steatotic liver disease.